BioAge Labs (BIOA) Retained Earnings (2023 - 2026)
BioAge Labs' (BIOA) quarterly Retained Earnings came in at $757.2 million in Q2 2026, up 30.12% year-over-year from $581.9 million in Q2 2025, and up 3.05% quarter-over-quarter from $734.7 million in Q1 2026.
Analysis
BioAge Labs (BIOA) Retained Earnings (2023 - 2026) Analysis & Trends
BioAge Labs has disclosed Retained Earnings across 4 years of filings, most recently posting $757.2 million for Q2 2026.
- In Q2 2026, Retained Earnings rose 30.12% year-over-year to $757.2 million; the TTM figure through Jun 2026 stood at $757.2 million (up 30.12% YoY), while the FY2025 annual figure was $605.2 million, up 5.12% from the prior year.
- Retained Earnings came in at $757.2 million for Q2 2026 at BioAge Labs, up from $734.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $757.2 million in Q2 2026 to a low of -$181.7 million in Q4 2023.
- Average Retained Earnings over 4 years is $531.3 million, with a median of $581.9 million recorded in 2025.
- Year-over-year, Retained Earnings surged 416.83% in 2024 and gained 5.12% in 2025.
- Over 4 years, Retained Earnings stood at -$181.7 million in 2023, then surged by 416.83% to $575.7 million in 2024, then grew by 5.12% to $605.2 million in 2025, then grew by 25.11% to $757.2 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $757.2 million in Q2 2026, $734.7 million in Q1 2026, and $605.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -22.28 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 9.53 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 15.69 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 37.62 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 558.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 20.97 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 6.57 Bn |
| 10 | BioAge Labs | 439.00 Mn | 439.00 Mn | -14.23 Mn | 757.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 757.16 Mn |
| Mar 31, 2026 | 734.72 Mn |
| Dec 31, 2025 | 605.19 Mn |
| Sep 30, 2025 | 584.66 Mn |
| Jun 30, 2025 | 581.87 Mn |
| Mar 31, 2025 | 578.64 Mn |
| Dec 31, 2024 | 575.69 Mn |
| Sep 30, 2024 | 545.32 Mn |
| Dec 31, 2023 | -181.70 Mn |